Cargando…
Licensed liposomal vaccines and adjuvants in the antigen delivery system
Liposomes (LSs) are promising nanoparticles with unique properties such as controlled nanosize, large surface area, increased reactivity, and ability to undergo modification. Worldwide, licensed liposomal forms of antibiotics, hormones, antioxidants, cytostatics, ophthalmic drugs, etc., are availabl...
Autores principales: | Krasnopolsky, Yuriy, Pylypenko, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837556/ https://www.ncbi.nlm.nih.gov/pubmed/36685697 http://dx.doi.org/10.5114/bta.2022.120709 |
Ejemplares similares
-
Liposomes: from August Wassermann to vaccines against COVID-19
por: Grygorieva, Ganna, et al.
Publicado: (2023) -
Liposomes as Adjuvants and Vaccine Delivery Systems
por: Tretiakova, D. S., et al.
Publicado: (2022) -
Liposomal delivery system/adjuvant for tuberculosis vaccine
por: Moradi, Melika, et al.
Publicado: (2023) -
Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery
por: Wang, Zhi-Biao, et al.
Publicado: (2020) -
Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
por: Heuts, Jeroen, et al.
Publicado: (2018)